Sargent CA - Search Results

1

The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.

Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. Grover GJ, et al. Among authors: sargent ca. J Pharmacol Exp Ther. 1993 May;265(2):559-64. J Pharmacol Exp Ther. 1993. PMID: 8496806

2

Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts.

Sargent CA, Sleph PG, Dzwonczyk S, Smith MA, Grover GJ. Sargent CA, et al. J Cardiovasc Pharmacol. 1992 Aug;20(2):251-60. doi: 10.1097/00005344-199208000-00010. J Cardiovasc Pharmacol. 1992. PMID: 1381016

3

Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.

Sargent CA, Vesterqvist O, McCullough JR, Ogletree ML, Grover GJ. Sargent CA, et al. J Pharmacol Exp Ther. 1992 Sep;262(3):1161-7. J Pharmacol Exp Ther. 1992. PMID: 1382129

4

Effect of the potassium channel opener EMD 56431 on globally ischemic rat hearts.

Sargent CA, Dzwonczyk S, Grover GJ. Sargent CA, et al. Pharmacology. 1992;45(5):260-8. doi: 10.1159/000139009. Pharmacology. 1992. PMID: 1465473

5

Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.

Sargent CA, Smith MA, Dzwonczyk S, Sleph PG, Grover GJ. Sargent CA, et al. J Pharmacol Exp Ther. 1991 Oct;259(1):97-103. J Pharmacol Exp Ther. 1991. PMID: 1920138

6

Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075.

Sargent CA, Sleph PG, Dzwonczyk S, Normandin D, Antonaccio MJ, Grover GJ. Sargent CA, et al. J Cardiovasc Pharmacol. 1993 Oct;22(4):564-70. doi: 10.1097/00005344-199310000-00009. J Cardiovasc Pharmacol. 1993. PMID: 7505358

7

Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat hearts.

Grover GJ, Sargent CA, Dzwonczyk S, Normandin DE, Antonaccio MJ. Grover GJ, et al. Among authors: sargent ca. J Cardiovasc Pharmacol. 1993 Oct;22(4):664-72. doi: 10.1097/00005344-199310000-00022. J Cardiovasc Pharmacol. 1993. PMID: 7505371

8

Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.

Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA, Atwal KS. Grover GJ, et al. Among authors: sargent ca. J Cardiovasc Pharmacol. 1995 Jan;25(1):40-50. doi: 10.1097/00005344-199501000-00008. J Cardiovasc Pharmacol. 1995. PMID: 7723352

9

Pyruvate increases threshold for preconditioning in globally ischemic rat hearts.

Sargent CA, Dzwonczyk S, Sleph P, Wilde M, Grover GJ. Sargent CA, et al. Am J Physiol. 1994 Oct;267(4 Pt 2):H1403-9. doi: 10.1152/ajpheart.1994.267.4.H1403. Am J Physiol. 1994. PMID: 7943385

10

The effect of alpha 2-adrenoceptor antagonists in isolated globally ischemic rat hearts.

Sargent CA, Dzwonczyk S, Grover GJ. Sargent CA, et al. Eur J Pharmacol. 1994 Aug 11;261(1-2):25-32. doi: 10.1016/0014-2999(94)90296-8. Eur J Pharmacol. 1994. PMID: 8001650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters